Atanasio
Pandiella Alonso
Consejo Superior de Investigaciones Científicas
Madrid, EspañaPublicacións en colaboración con investigadores/as de Consejo Superior de Investigaciones Científicas (32)
2022
-
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology
Cancers, Vol. 14, Núm. 14
-
Genomic mapping of copy number variations influencing immune response in breast cancer
Frontiers in Oncology, Vol. 12
-
HER3 in cancer: from the bench to the bedside
Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1
-
Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21
Cancer Research, Vol. 82, Núm. 3, pp. 447-457
-
Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis
Therapeutic Advances in Medical Oncology, Vol. 14
2021
-
Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma
Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1
-
Generation of antibody‐drug conjugate resistant models
Cancers, Vol. 13, Núm. 18
-
Genomic mapping of splicing-related genes identify amplifications in lsm1, clns1a, and ilf2 in luminal breast cancer
Cancers, Vol. 13, Núm. 16
-
MZ1 co-operates with trastuzumab in HER2 positive breast cancer
Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1
-
Mapping of genomic vulnerabilities in the post-translational ubiquitination, sumoylation and neddylation machinery in breast cancer
Cancers, Vol. 13, Núm. 4, pp. 1-23
-
Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer
Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1
-
PDCD4 limits prooncogenic neuregulin-ErbB signaling
Cellular and Molecular Life Sciences, Vol. 78, Núm. 4, pp. 1799-1815
-
Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer
Frontiers in Oncology, Vol. 11
-
Transcriptomic profiles of cd47 in breast tumors predict outcome and are associated with immune activation
International Journal of Molecular Sciences, Vol. 22, Núm. 8
2020
-
Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
Frontiers in Oncology, Vol. 10
-
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies
EMBO Molecular Medicine, Vol. 12, Núm. 5
-
Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer
Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 5, pp. 3117-3127
2019
-
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer
Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1
2018
-
Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer
International Journal of Oncology, Vol. 53, Núm. 1, pp. 113-123
-
Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: Understanding clinical trial results
Oncotarget, Vol. 9, Núm. 61, pp. 31915-31919